MIDAS PHARMA GMBH
Overview
MIDAS PHARMA GMBH is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering 5-AMINOLEVULINIC ACID HYDROCHLORIDE; CLOFAZIMINE; CROTAMITON; DIETHYLPROPIONE HCL; DOXAPRAM HYDROCHLORIDE; INTERMEDIATE (R)-3-QUINUCLIDINOL.
API / Drug Master Files
MIDAS PHARMA GMBH holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- PROPOFOLActive2025-05-22
- INTERMEDIATE (R)-3-QUINUCLIDINOLActive2021-12-23
- CLOFAZIMINEActive2019-11-18
- CROTAMITONActive2018-09-28
- DOXAPRAM HYDROCHLORIDEActive2018-01-26
- 5-AMINOLEVULINIC ACID HYDROCHLORIDEActive2015-05-27
- DIETHYLPROPIONE HCLActive1978-11-30
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to MIDAS PHARMA GMBH in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.